Literature DB >> 9210056

Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas.

H Kawamoto1, T Mizoue, K Arita, A Tominaga, K Eguchi, K Kurisu.   

Abstract

Pituitary adenomas generally are regarded as benign tumors, although some invade the cavernous sinus and recur. We examined the epithelial cadherin (E-CD) expression in 30 pituitary adenomas (6 with cavernous sinus invasion and 24 without). Immunoreactivity of E-CD were found in all pituitary adenomas but they were very various. The presence of an association between E-CD expression and cavernous sinus invasion was assessed. There were no significant differences in E-CD expression between invasive and noninvasive adenomas. These results suggest that E-CD expression is not associated with cavernous sinus invasion in pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210056     DOI: 10.1023/a:1005709014239

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  Decreased expression of E-cadherin in the progression of rat prostatic cancer.

Authors:  M J Bussemakers; R J van Moorselaar; L A Giroldi; T Ichikawa; J T Isaacs; M Takeichi; F M Debruyne; J A Schalken
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

2.  Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel.

Authors:  G Gagliardi; O Kandemir; D Liu; M Guida; S Benvestito; T G Ruers; I S Benjamin; J M Northover; G W Stamp; I C Talbot
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors.

Authors:  D Figarella-Branger; H Lepidi; C Poncet; D Gambarelli; N Bianco; G Rougon; J F Pellissier
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.

Authors:  R A Morton; C M Ewing; A Nagafuchi; S Tsukita; W B Isaacs
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

5.  E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.

Authors:  B Mayer; J P Johnson; F Leitl; K W Jauch; M M Heiss; F W Schildberg; W Birchmeier; I Funke
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

6.  Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer.

Authors:  P K Lipponen; M J Eskelinen
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Neural cell adhesion molecule expression in human pituitary adenomas.

Authors:  B K Kleinschmidt-DeMasters; D R Conway; W A Franklin; K O Lillehei; C A Kruse
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas.

Authors:  G F Scheumman; C Hoang-Vu; Y Cetin; O Gimm; J Behrends; R von Wasielewski; A Georgii; W Birchmeier; A von Zur Mühlen; H Dralle
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

9.  Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.

Authors:  M Pignatelli; T W Ansari; P Gunter; D Liu; S Hirano; M Takeichi; G Klöppel; N R Lemoine
Journal:  J Pathol       Date:  1994-12       Impact factor: 7.996

10.  Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.

Authors:  H Kawamoto; T Uozumi; K Kawamoto; K Arita; T Yano; T Hirohata
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

View more
  7 in total

1.  Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.

Authors:  Bing Xu; Toshiaki Sano; Katsuhiko Yoshimoto; Shozo Yamada
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.

Authors:  Johan Arild Evang; Jens Bollerslev; Olivera Casar-Borota; Tove Lekva; Jon Ramm-Pettersen; Jens Petter Berg
Journal:  Endocrine       Date:  2013-01-13       Impact factor: 3.633

Review 3.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

4.  Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.

Authors:  G A Mendes; T Haag; G Trott; C G S L Rech; N P Ferreira; M C Oliveira; M B Kohek; J F S Pereira-Lima
Journal:  Braz J Med Biol Res       Date:  2017-12-11       Impact factor: 2.590

5.  E-cadherin expression is associated with somatostatin analogue response in acromegaly.

Authors:  Eva Venegas-Moreno; Alvaro Flores-Martinez; Elena Dios; Mari C Vazquez-Borrego; Alejandro Ibañez-Costa; Ainara Madrazo-Atutxa; Miguel A Japón; Justo P Castaño; Raúl M Luque; David A Cano; Alfonso Soto-Moreno
Journal:  J Cell Mol Med       Date:  2019-03-06       Impact factor: 5.310

Review 6.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

Review 7.  The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature.

Authors:  Matthew Pease; Chao Ling; William J Mack; Kai Wang; Gabriel Zada
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.